DOV-102,677
DOV-102,677 is an orally sctive triple monoamine neurotransmitter reuptake inhibitor that simultaneously inhibits the dopamine (DAT) (IC50 = 129 nM; Ki = 222 nM), norepinephrine (NET) (IC50 = 103 nM; Ki = 1030 nM), and serotonin (SERT) (IC50 = 133 nM; Ki = 740 nM) transporters. DOV-102,677 demonstrated significant antidepressant-like activity and sensory-motor gating regulatory effects in mouse experiments. DOV-102,677 can be used for research on depression[1].
Product Specifications
CAS Number
410074-75-8
UNSPSC
12352005
Target
5-HT Receptor; Adrenergic Receptor; Dopamine Transporter
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
ClC1=CC=C([C@@]23CNC[C@]2([H])C3)C=C1Cl
Molecular Formula
C11H11Cl2N
Molecular Weight
228.12
References & Citations
[1] Shao L, et al. Discovery of N-methyl-1- (1-phenylcyclohexyl) methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor. Bioorg Med Chem Lett. 2011 Mar 1;21 (5) :1438-41|[2]Prins J, et al. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats. Eur J Pharmacol. 2010 May 10;633 (1-3) :55-61
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC400960 20 µg
Prolyl Endopeptidase (PREP) (NM_002726) Human Over-expression Lysate
Sign In for Pricing
View Details 
